These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 27212031)
1. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia. Martinelli GB; Olivari D; Re Cecconi AD; Talamini L; Ottoboni L; Lecker SH; Stretch C; Baracos VE; Bathe OF; Resovi A; Giavazzi R; Cervo L; Piccirillo R Oncogene; 2016 Dec; 35(48):6212-6222. PubMed ID: 27212031 [TBL] [Abstract][Full Text] [Related]
2. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy. Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585 [TBL] [Abstract][Full Text] [Related]
3. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway. Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837 [TBL] [Abstract][Full Text] [Related]
4. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia. Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162 [TBL] [Abstract][Full Text] [Related]
5. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice. Chen L; Chen L; Wan L; Huo Y; Huang J; Li J; Lu J; Xin B; Yang Q; Guo C Oncol Rep; 2019 Aug; 42(2):479-494. PubMed ID: 31233199 [TBL] [Abstract][Full Text] [Related]
6. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study. Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630 [TBL] [Abstract][Full Text] [Related]
7. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia. Fukawa T; Yan-Jiang BC; Min-Wen JC; Jun-Hao ET; Huang D; Qian CN; Ong P; Li Z; Chen S; Mak SY; Lim WJ; Kanayama HO; Mohan RE; Wang RR; Lai JH; Chua C; Ong HS; Tan KK; Ho YS; Tan IB; Teh BT; Shyh-Chang N Nat Med; 2016 Jun; 22(6):666-71. PubMed ID: 27135739 [TBL] [Abstract][Full Text] [Related]
8. Long-noncoding RNA Atrolnc-1 promotes muscle wasting in mice with chronic kidney disease. Sun L; Si M; Liu X; Choi JM; Wang Y; Thomas SS; Peng H; Hu Z J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):962-974. PubMed ID: 30043444 [TBL] [Abstract][Full Text] [Related]
9. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation. Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525 [TBL] [Abstract][Full Text] [Related]
10. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300. Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181 [TBL] [Abstract][Full Text] [Related]
11. SDF‑1/CXCR4 induces epithelial‑mesenchymal transition through activation of the Wnt/β‑catenin signaling pathway in rat chronic allograft nephropathy. Tang H; Xu Y; Zhang Z; Zeng S; Dong W; Jiao W; Hu X Mol Med Rep; 2019 May; 19(5):3696-3706. PubMed ID: 30896799 [TBL] [Abstract][Full Text] [Related]
12. The CXCR4/SDF1 axis improves muscle regeneration through MMP-10 activity. Bobadilla M; Sainz N; Abizanda G; Orbe J; Rodriguez JA; Páramo JA; Prósper F; Pérez-Ruiz A Stem Cells Dev; 2014 Jun; 23(12):1417-27. PubMed ID: 24548137 [TBL] [Abstract][Full Text] [Related]
13. Effects of the beta Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866 [TBL] [Abstract][Full Text] [Related]
14. The p97-Nploc4 ATPase complex plays a role in muscle atrophy during cancer and amyotrophic lateral sclerosis. Re Cecconi AD; Barone M; Gaspari S; Tortarolo M; Bendotti C; Porcu L; Terribile G; Piccirillo R J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2225-2241. PubMed ID: 35611892 [TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice. Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608 [TBL] [Abstract][Full Text] [Related]
16. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype. Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129 [TBL] [Abstract][Full Text] [Related]
17. Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle. Pretto F; Ghilardi C; Moschetta M; Bassi A; Rovida A; Scarlato V; Talamini L; Fiordaliso F; Bisighini C; Damia G; Bani MR; Piccirillo R; Giavazzi R Oncotarget; 2015 Feb; 6(5):3043-54. PubMed ID: 25460504 [TBL] [Abstract][Full Text] [Related]
18. Exercise training reverses cancer-induced oxidative stress and decrease in muscle COPS2/TRIP15/ALIEN. Alves CRR; Neves WD; de Almeida NR; Eichelberger EJ; Jannig PR; Voltarelli VA; Tobias GC; Bechara LRG; de Paula Faria D; Alves MJN; Hagen L; Sharma A; Slupphaug G; Moreira JBN; Wisloff U; Hirshman MF; Negrão CE; de Castro G; Chammas R; Swoboda KJ; Ruas JL; Goodyear LJ; Brum PC Mol Metab; 2020 Sep; 39():101012. PubMed ID: 32408015 [TBL] [Abstract][Full Text] [Related]
19. Myostatin is a novel tumoral factor that induces cancer cachexia. Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320 [TBL] [Abstract][Full Text] [Related]
20. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]